Advertisement
Screener

EyePoint, Inc. (EYPT) Cash and Cash Equivalents, Period Increase (Decrease)

EyePoint, Inc. Cash and Cash Equivalents, Period Increase (Decrease)

EyePoint, Inc. (EYPT) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$552.00 thousand for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-05-10

  • EyePoint, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $3.47M, a 192.58% increase year-over-year.
  • EyePoint, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $1.04M.
  • EyePoint, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$5.07M.
  • EyePoint, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $4.03M.
  • EyePoint, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $1.58M.
  • EyePoint, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$3.81M, a 200.55% decline from fiscal 2015.
  • EyePoint, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $3.79M, a 55.10% decline from fiscal 2014.
  • EyePoint, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $8.44M, a 270.93% increase from fiscal 2013.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2018-03-31$3.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10
$4.51M
derived: sum of 2 quarters · filed 2018-05-10
-$552.00K
10-Q · filed 2018-05-10
$3.48M
derived: sum of 4 quarters · filed 2018-05-10
2017-12-31$1.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08
-$4.02M
10-Q · filed 2018-02-08
$5.00K
derived: sum of 3 quarters · filed 2018-02-08
$1.19M
derived: sum of 4 quarters · filed 2018-05-10
2017-09-30-$5.07M
10-Q · filed 2017-11-08
-$1.04M
derived: sum of 2 quarters · filed 2017-11-08
$148.00K
derived: sum of 3 quarters · filed 2018-05-10
-$2.48M
derived: sum of 4 quarters · filed 2018-05-10
2017-06-30$4.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-13
$5.21M
derived: sum of 2 quarters · filed 2018-05-10
$2.59M
derived: sum of 3 quarters · filed 2018-05-10
$1.58M
10-K · filed 2017-09-13
2017-03-31$1.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10
-$1.44M
derived: sum of 2 quarters · filed 2018-05-10
-$2.44M
10-Q · filed 2018-05-10
-$12.00M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31-$2.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08
-$3.63M
10-Q · filed 2018-02-08
-$13.18M
derived: sum of 3 quarters · filed 2018-02-08
$475.00K
derived: sum of 4 quarters · filed 2018-02-08
2016-09-30-$1.00M
10-Q · filed 2017-11-08
-$10.56M
derived: sum of 2 quarters · filed 2017-11-08
$3.10M
derived: sum of 3 quarters · filed 2017-11-08
$220.00K
derived: sum of 4 quarters · filed 2017-11-08
2016-06-30-$9.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-13
$4.10M
derived: sum of 2 quarters · filed 2017-09-13
$1.23M
derived: sum of 3 quarters · filed 2017-09-13
-$3.81M
10-K · filed 2017-09-13
2016-03-31$13.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08
$10.78M
derived: sum of 2 quarters · filed 2017-05-08
$5.75M
10-Q · filed 2017-05-08
$1.86M
derived: sum of 4 quarters · filed 2017-09-13
2015-12-31-$2.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09
-$7.91M
10-Q · filed 2017-02-09
-$11.80M
derived: sum of 3 quarters · filed 2017-09-13
-$18.54M
derived: sum of 4 quarters · filed 2017-09-13
2015-09-30-$5.03M
10-Q · filed 2016-11-08
-$8.92M
derived: sum of 2 quarters · filed 2017-09-13
-$15.66M
derived: sum of 3 quarters · filed 2017-09-13
$2.70M
derived: sum of 4 quarters · filed 2017-09-13
2015-06-30-$3.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-13
-$10.63M
derived: sum of 2 quarters · filed 2017-09-13
$7.74M
derived: sum of 3 quarters · filed 2017-09-13
$3.79M
10-K · filed 2017-09-13
2015-03-31-$6.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-06
$11.62M
derived: sum of 2 quarters · filed 2016-05-06
$7.67M
10-Q · filed 2016-05-06
$4.45M
derived: sum of 4 quarters · filed 2016-09-13
2014-12-31$18.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09
$14.42M
10-Q · filed 2016-02-09
$11.20M
derived: sum of 3 quarters · filed 2016-09-13
$14.53M
derived: sum of 4 quarters · filed 2016-09-13
2014-09-30-$3.95M
10-Q · filed 2015-11-06
-$7.17M
derived: sum of 2 quarters · filed 2016-09-13
-$3.83M
derived: sum of 3 quarters · filed 2016-09-13
-$3.16M
derived: sum of 4 quarters · filed 2016-09-13
2014-06-30-$3.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13
$115.00K
derived: sum of 2 quarters · filed 2016-09-13
$788.00K
derived: sum of 3 quarters · filed 2016-09-13
$8.44M
10-K · filed 2016-09-13
2014-03-31$3.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-08
$4.01M
derived: sum of 2 quarters · filed 2015-05-08
$11.66M
10-Q · filed 2015-05-08
$10.56M
derived: sum of 4 quarters · filed 2015-09-10
2013-12-31$673.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06
$8.32M
10-Q · filed 2015-02-06
$7.22M
derived: sum of 3 quarters · filed 2015-09-10
$5.81M
derived: sum of 4 quarters · filed 2015-09-10
2013-09-30$7.65M
10-Q · filed 2014-11-07
$6.55M
derived: sum of 2 quarters · filed 2015-09-10
$5.14M
derived: sum of 3 quarters · filed 2015-09-10
$6.16M
derived: sum of 4 quarters · filed 2015-09-10
2013-06-30-$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-10
-$2.51M
derived: sum of 2 quarters · filed 2015-09-10
-$1.49M
derived: sum of 3 quarters · filed 2015-09-10
$2.27M
10-K · filed 2015-09-10
2013-03-31-$1.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14
-$390.00K
derived: sum of 2 quarters · filed 2014-05-14
$3.37M
10-Q · filed 2014-05-14
$1.62M
derived: sum of 4 quarters · filed 2014-09-11
2012-12-31$1.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-12
$4.78M
10-Q · filed 2014-02-12
$3.03M
derived: sum of 3 quarters · filed 2014-09-11
$1.00M
derived: sum of 4 quarters · filed 2014-09-11
2012-09-30$3.76M
10-Q · filed 2013-11-13
$2.01M
derived: sum of 2 quarters · filed 2014-09-11
-$20.00K
derived: sum of 3 quarters · filed 2014-09-11
-$1.42M
derived: sum of 4 quarters · filed 2014-09-11
2012-06-30-$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11
-$3.78M
derived: sum of 2 quarters · filed 2014-09-11
-$5.19M
derived: sum of 3 quarters · filed 2014-09-11
-$8.29M
10-K · filed 2014-09-11
2012-03-31-$2.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14
-$3.44M
derived: sum of 2 quarters · filed 2013-05-14
-$6.54M
10-Q · filed 2013-05-14
-$6.92M
derived: sum of 4 quarters · filed 2013-09-27
2011-12-31-$1.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-08
-$4.50M
10-Q · filed 2013-02-08
-$4.89M
derived: sum of 3 quarters · filed 2013-09-27
$1.03M
derived: sum of 4 quarters · filed 2013-09-27
2011-09-30-$3.10M
10-Q · filed 2012-11-09
-$3.48M
derived: sum of 2 quarters · filed 2013-09-27
$2.43M
derived: sum of 3 quarters · filed 2013-09-27
-$315.00K
derived: sum of 4 quarters · filed 2013-09-27
2011-06-30-$384.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27
$5.54M
derived: sum of 2 quarters · filed 2013-09-27
$2.79M
derived: sum of 3 quarters · filed 2013-09-27
-$2.60M
10-K · filed 2013-09-27
2011-03-31$5.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10
$3.17M
derived: sum of 2 quarters · filed 2012-05-10
-$2.22M
10-Q · filed 2012-05-10
2010-12-31-$2.75M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-09
-$8.14M
10-Q · filed 2012-02-09
2010-09-30-$5.39M
10-Q/A · filed 2011-11-09
2010-06-30$8.62M
10-K · filed 2012-09-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15